Abstract
Gatherings in groups are a ubiquitous phenomenon throughout human history. This is true for everyday social tasks as well as for healing and spiritual purposes. In psychotherapy, group treatment started soon after developing psychoanalytic treatment procedures. For psychedelic therapy however, individual treatment guided by one or sometimes even two therapists is the most common and widespread treatment model for clinical research and therapy thus far. Since the foundation of the Swiss Medical Society for Psycholytic Therapy (Schweizerische Ärztegesellschaft für psycholytische Therapie, SÄPT) in 1985 in Switzerland, we however had the opportunity to conduct psychedelic group treatment in specific settings, which the following article describes.
In this article, the terms “psycholytic” and “psychedelic” are used as synonyms. In addition, I chose the term “patient” for the person coming to treatment. It is the common labelling in medicine, lent from Latin and means “the one who has patience”, which in fact is necessary for most psychological treatments. I care about both genders including description, although this is not always visible in English. In general, both genders are included.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Barkowski S, Schwartze D, Strauss B, Burlingame GM, Rosendahl J (2020) Efficacy of group psychotherapy for anxiety disorders: a systematic review and meta-analysis. Psychother Res 30(8):965–982. https://doi.org/10.1080/10503307.2020.1729440
Benz E (1989) Halluzinogen-unterstützte Psychotherapie. Erhebung bei der Schweizerischen Ärzte-gesellschaft für Psycholytische Therapie. Universität Zürich. Dissertation
Eliade M (1974) Schamanismus und archaische Ekstasetechnik. Suhrkamp, Frankfurt
Furst PT (1972) Flesh of the gods: the ritual use of hallucinogens. Praeger Publishers, New York
Gasser P (1996) Die Psycholytische Therapie in der Schweiz von 1988 – 1993. Schweiz Arch Neurol Psych 147:59–65
Gasser P (2017) Research update: psychedelic group therapy in Switzerland. MAPS Bulletin 27(1):28–29
Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. Nerv Ment Dis 202(7):513–520. https://doi.org/10.1097/NMD.0000000000000113
Grawe K, Donati R, Bernauer F (1994) Psychotherapie im Wandel. Von der Konfession zur Profession. Hogrefe, Göttingen
Harner M (1990) The way of the shaman. Harper One, San Francisco
Homan JE (2011) Charlatans, seekers, and shamans: the ayahuasca boom in western Peruvian Amazonia. Master thesis, University of Kansas
Jungaberle H, Verres R (2008) Regeln und Standards in der substanzunterstützten Psychotherapie (SPT). In: Jungaberle H, Gasser P, Weinhold J, Verres R (eds) Therapie mit Psychoaktiven Substanzen. Praxis und Kritik der Psychotherapie mit LSD, Psilocybin und MDMA. Huber, Bern, pp 41–109
Liggenstorfer R, Raetsch C (eds) (1996) Maria Sabina, Botin der heiligen Pilze. Nachtschatten Verlag, Solothurn
McDermut W, Miller IW, Brown RA (2001) The efficacy of group psychotherapy for depression: a meta-analysis and review of the empirical research. In: Database of abstracts of reviews of effects (DARE): quality-assessed reviews [internet]. Centre for Reviews and Dissemination, York, 1995. https://www.ncbi.nlm.nih.gov/books/NBK68475/
Meckel Fischer F (2015) Therapy with substance. Muswell Hill Press, London
Oehen P, Traber R, Widmer V, Schnyder U (2013) A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). Psychopharmacology 27(1):40–52. https://doi.org/10.1177/0269881112464827
Rutan JS (1993) Psychoanalytic group psychotherapy. In: Kaplan HI, Sadock BJ (eds) Comprehensive group psychotherapy. Lippincott Williams and Wilkins, Philadelphia, pp 138–146
Scharfetter C (1997) Der spirituelle Weg und seine Gefahren. Enke, Stuttgart
Schmid Y, Gasser P, Oehen P, Liechti ME (2020) Acute subjective effects in LSD- and MDMA-assisted psychotherapy. J Psychopharmacol 35:362–374. https://doi.org/10.1177/0269881120959604
Stolaroff MJ (1997) The secret chief: conversations with a pioneer of the underground psychedelic therapy movement. Multidisciplinary Association for Psychedelic Studies (MAPS), Charlotte
Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD (2019) Psychedelic-assisted group therapy: a systematic review. J Psychoactive Drugs 51(2):174–188. https://doi.org/10.1080/02791072.2019.1593559
Wampold BE (2015) How important are the common factors in psychotherapy? An update. World Psychiatry 14(3):270–277. https://doi.org/10.1002/wps.20238
Yalom ID (1995) The theory and practice of group therapy. Basic Books, New York. German edition: Yalom ID (1996) Theorie und Praxis der Gruppenpsychotherapie. Klett-Cotta, Stuttgart
Yalom ID (2005) The Schopenhauer cure. Harper and Collins, New York
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gasser, P. (2021). Psychedelic Group Therapy. In: Barrett, F.S., Preller, K.H. (eds) Disruptive Psychopharmacology . Current Topics in Behavioral Neurosciences, vol 56. Springer, Cham. https://doi.org/10.1007/7854_2021_268
Download citation
DOI: https://doi.org/10.1007/7854_2021_268
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-12183-8
Online ISBN: 978-3-031-12184-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)